Drug Type Small molecule drug |
Synonyms Travoprost/brinzolamide |
Target |
Mechanism CA2 inhibitors(Carbonic anhydrase II inhibitors), PTGFR agonists(Prostanoid FP receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H21N3O5S3 |
InChIKeyHCRKCZRJWPKOAR-JTQLQIEISA-N |
CAS Registry138890-62-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glaucoma | Phase 3 | BE | 01 Oct 2008 | |
Glaucoma | Phase 3 | MX | 01 Oct 2008 | |
Glaucoma, Open-Angle | Phase 2 | US | 01 Aug 2007 |